Sandro Anchisi
Hôpital du Valais(CH)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies, Healthcare Systems and Practices, Health, Medicine and Society, Bone health and treatments
Most-Cited Works
- → Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes(2000)148 cited
- → Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)(2015)140 cited
- → Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial(2017)120 cited
- → Mental neuropathy: report of five cases and review of the literature(2000)113 cited
- → Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)(2011)80 cited
- → Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment(2013)69 cited
- → SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial(2016)46 cited
- → Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: A randomized phase III noninferiority trial (SAKK 41/06).(2013)29 cited
- → Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data(2018)21 cited
- → Patients' experiences with cancer care in Switzerland: Results of a multicentre cross‐sectional survey(2022)20 cited